ONTRALOG Trademark

Trademark Overview

On Thursday, June 22, 2023, a trademark application was filed for ONTRALOG with the United States Patent and Trademark Office. The USPTO has given the ONTRALOG trademark a serial number of 98054629. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, June 13, 2025. This trademark is owned by Sanofi. The ONTRALOG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating diabetes
ontralog

General Information

Serial Number98054629
Word MarkONTRALOG
Filing DateThursday, June 22, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, June 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75017
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75017
FR

Trademark Events

Event DateEvent Description
Monday, June 26, 2023NEW APPLICATION ENTERED
Friday, June 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 12, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, September 13, 2023ASSIGNED TO EXAMINER
Thursday, September 14, 2023ATTORNEY REVIEW COMPLETED
Friday, September 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 6, 2024SOU EXTENSION 1 GRANTED
Monday, May 6, 2024SOU TEAS EXTENSION RECEIVED
Monday, May 6, 2024SOU EXTENSION 1 FILED
Wednesday, November 6, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 6, 2024SOU EXTENSION 2 GRANTED
Wednesday, November 6, 2024SOU EXTENSION 2 FILED
Tuesday, May 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 13, 2025SOU TEAS EXTENSION RECEIVED
Friday, June 13, 2025SOU EXTENSION 3 FILED
Monday, June 30, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 30, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 30, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, June 30, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 13, 2025SOU EXTENSION 3 GRANTED

Related Keywords

ontralog diabetes treating preparations pharmaceutical